Direct primary care startup Hint Health raised $45 million in a funding round led by Banneker Partners and Frist Cressey Ventures, bringing its total raise to $60 million.
Hint offers a platform where providers can enroll patients as members and directly bill for services. The company said the funding will go toward growing its operating system and expanding its primary care provider network. They’ll also expand support for virtual-first models and workplace clinics that contract directly with employers.
“With Hint Health, providers can deliver premium and affordable care to all without dealing with the hassle and costs associated with the insurance middlemen, meaning providers can put the focus back on their patients,” CEO Zak Holdsworth said in a statement. “For patients, this means the high-touch care they need, but at an affordable price that makes healthcare accessible and realigns payment incentives toward value.”
Autism care startup SpectrumAi raised $9 million in a seed funding round led by F-Prime Capital and Frist Cressey Ventures, with participation from Autism Impact Fund.
The startup’s tools aim to analyze quality and outcomes data on applied behavior analysis (ABA), with the goal of eventually enabling a value-based contracting model for the therapy.
“As a parent of four autistic sons, I know the challenges of autism and have witnessed the power of excellence in ABA therapy. However, I also understand the quality of care varies dramatically. SpectrumAi seeks to address this issue by bringing outcomes clarity and measurement to the highly subjective and fragmented ABA space,” founder and CEO Ling Shao said in a statement.
Massive Bio, which offers a platform to help cancer patients find and enroll in clinical trials, announced it had $9 million in financing.
The round was led by Revo Capital and Kenan Turnacioğlu, chair of PaigeAI’s board of directors, with participation from DEG. The startup plans to use the investment to grow its operations globally, for marketing and to launch new products.
“Our passion, dedication, perseverance, and smart work [have] led to the company’s success and expansion in 12 markets without a sales force or marketing. Having the financial support, healthcare expertise and global coverage of investors such as DEG and Kenan, along with heavy technology expertise of our existing investors like Revo Capital, will help us execute our goals globally and at an accelerated scale,” cofounder and CEO Selin Kurnaz said in a statement.